http://biz.yahoo.com/ic/news/513.htmlThe latest news on the Drug Delivery industry from Yahoo! Financeen-usWed, 10 Feb 2010 13:46:11 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7b21E7FA46-9740-458B-AAD8-62D3DB7904CC%7d&siteid=yhoof2yahoo_finance/2786756143Wed, 10 Feb 2010 13:46:11 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100210/20100210005301.html?.v=1TORONTO----Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL , has entered into a collaboration and license agreement with Alexza Pharmaceuticals, Inc.yahoo_finance/1246572504Wed, 10 Feb 2010 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/100210/sf52763.html?.v=1Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation , to develop and commercialize AZ-004 in the U.S. and Canada.  AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system.  Alexza submitted its New Drug Application for Staccato loxapine in December 2009.  Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.  yahoo_finance/3631539141Wed, 10 Feb 2010 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7bBE3CF61D-C4F3-4B3D-88AB-C7C29E026EF1%7d&siteid=yhoof2yahoo_finance/1345906686Wed, 10 Feb 2010 07:26:45 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100210/20100209007397.html?.v=1DUBLIN----Elan Corporation, plc today reported its fourth quarter and full-year 2009 financial results and provides financial guidance for 2010.yahoo_finance/2217193977Wed, 10 Feb 2010 07:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/100209/30363.html?.v=1yahoo_finance/2941668155Tue, 9 Feb 2010 21:18:06 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12livt77p/*http%3A//seekingalpha.com/article/187575-chemgenex-a-snow-fueled-setback-at-the-fda?source=yahooyahoo_finance/32365690Tue, 9 Feb 2010 18:33:41 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12o2na7ak/*http%3A//www.marketwatch.com/news/story/biogen-reports-higher-profit-raises/story.aspx?guid=%7B54250673%2D0F25%2D4DB2%2D91DC%2DE70D2035F130%7D&siteid=yhoofAn almost 40% jump in sales of its new multiple sclerosis drug Tysabri helps Biogen to higher profit.yahoo_finance/1402737344Tue, 9 Feb 2010 18:10:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/100209/us_earns_biogen_idec.html?.v=1Biogen Idec Inc. said Tuesday its profit rose 48 percent in the fourth quarter due to higher sales of its drug Tysabri, a treatment for multiple sclerosis and Crohn's disease.yahoo_finance/1703232376Tue, 9 Feb 2010 14:22:20 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/100209/183846.html?.v=1yahoo_finance/2542767864Tue, 9 Feb 2010 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/100209/sf51908.html?.v=1Delcath Systems, Inc. , a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today the signing of its first research, distribution, sales and marketing agreement for its Percutaneous Hepatic Perfusion System  .  The agreement grants Chi-Fu Trading Co., Ltd. the exclusive right to market and sell the Delcath PHP System in Taiwan for hepatic malignancies and infectious disease upon Taiwan Food and Drug Administration approval, and any other approved use, with a conditional option for Singapore. yahoo_finance/2359005469Tue, 9 Feb 2010 12:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/video/cnbc/rss/SIG=113mb0hsu/*http%3A//www.cnbc.com/id/15840232?play=1&video=1407888998&__source=yahoo%7Cheadline%7Cquote%7Cvideo%7C&par=yahooyahoo_finance/630106581Mon, 8 Feb 2010 14:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/100208/183758.html?.v=1yahoo_finance/2859393637Mon, 8 Feb 2010 11:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12m1fl22i/*http%3A//www.marketwatch.com/news/story/drug-stocks-fall-alkermes-rallies/story.aspx?guid=%7B9BE4FB2F%2D8804%2D4CC9%2D85D1%2D76D2DE159334%7D&siteid=yhoofDrug stocks fall while shares of Alkermes Inc. rally following an analyst upgrade.yahoo_finance/1878102547Fri, 5 Feb 2010 21:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12m2b7a9r/*http%3A//www.marketwatch.com/news/story/drug-stocks-slip-alkermes-rallies/story.aspx?guid=%7B9BE4FB2F%2D8804%2D4CC9%2D85D1%2D76D2DE159334%7D&siteid=yhoofDrug stocks dip in early action while shares of Alkermes Inc. rally following an analyst upgrade.yahoo_finance/4129350075Fri, 5 Feb 2010 15:54:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/100205/30226.html?.v=1Alkermes Inc. reported a third quarter fiscal 2010 net loss of 3 cents per share compared with a loss of 9 cents in the year-ago period.yahoo_finance/773279483Fri, 5 Feb 2010 15:14:40 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7b3BB6691D-4896-44EC-8891-D6557FDFECAE%7d&siteid=yhoof2yahoo_finance/338940768Fri, 5 Feb 2010 14:50:59 Etc/GMThttp://us.rd.yahoo.com/finance/external/trsa/rss/SIG=137pnuok9/*http%3A//seekingalpha.com/article/186818-alkermes-inc-f3q10-qtr-end-12-31-09-earnings-call-transcript?source=yahooyahoo_finance/4141098721Fri, 5 Feb 2010 03:44:11 Etc/GMThttp://us.rd.yahoo.com/finance/external/trsa/rss/SIG=12nsa9orf/*http%3A//seekingalpha.com/article/186801-hospira-inc-q4-2009-earnings-call-transcript?source=yahooyahoo_finance/4253163764Fri, 5 Feb 2010 02:25:16 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/100204/30187.html?.v=1yahoo_finance/2043469446Thu, 4 Feb 2010 21:11:01 Etc/GMT